Amneal Pharmaceuticals, Inc. Logo

Amneal Pharmaceuticals, Inc.

Develops & commercializes essential medicines: generics, injectables & specialty drugs.

AMRX | US

Overview

Corporate Details

ISIN(s):
US03168L1052
LEI:
Country:
United States of America
Address:
0
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Amneal Pharmaceuticals, Inc. is a fully-integrated global biopharmaceutical company engaged in the development, manufacturing, and commercialization of essential medicines. Its diverse portfolio features over 280 products, including generics, injectables, and specialty branded pharmaceuticals. The company operates through a robust generics business and a growing specialty division, with a strategic focus on complex medicines. Key therapeutic areas include oncology and central nervous system disorders like Parkinson's disease, complemented by public health initiatives to increase access to treatments such as Naloxone. A core competency is the development of first-to-file and first-to-market products, aiming to make quality healthcare more accessible and affordable for patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Amneal Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Amneal Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Amneal Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Inhibikase Therapeutics, Inc. Logo
Develops kinase inhibitors to treat neurodegenerative diseases like Parkinson's.
United States of America IKT
Inhibrx Biosciences, Inc. Logo
Clinical-stage biopharma developing novel biologic therapies for life-threatening cancers.
United States of America INBX
InMed Pharmaceuticals Inc. Logo
Develops cannabinoid drugs for unmet medical needs and supplies rare cannabinoids for B2B wellness.
United States of America INM
Inmune Bio, Inc. Logo
Develops immunotherapies reprogramming innate immunity for cancer, Alzheimer's, and inflammation.
United States of America INMB
Innate Pharma SA Logo
Developing first-in-class antibody immunotherapies for cancer via the innate immune system.
United States of America IPHA
INOVIO PHARMACEUTICALS, INC. Logo
Develops DNA medicines delivered via smart devices for cancer, HPV, and infectious diseases.
United States of America INO
Insight Molecular Diagnostics Inc. Logo
Develops molecular diagnostic tests for oncology and transplant monitoring for clinicians & researchers.
United States of America IMDX
INSMED Inc Logo
Develops and commercializes innovative therapies for serious and rare diseases.
United States of America INSM
Instil Bio, Inc. Logo
Developing autologous TIL cell therapies using a patient's own immune cells to fight solid tumors.
United States of America TIL
Intellia Therapeutics, Inc. Logo
Developing curative CRISPR/Cas9 genome editing therapies for severe genetic disorders.
United States of America NTLA

Talk to a Data Expert

Have a question? We'll get back to you promptly.